VascVersa Ltd

Back to portfolio

We have developed a fast, simple, and consistent method to generate valuable primary human vascular stem cells from a small, easily obtained sample of human umbilical cord blood.

These cells are of the highest quality and potency, which allows them to be the starting point for a wide range of applications in regenerative medicine research and therapy.

VascVersa is based on research from The Queens University of Belfast and led by Christina O’Neill. 

Visit website
  • Digital, Environmental, Engineering

    Catagen Ltd

    Creating a clean air future Advancing environmental standards

    Read more
  • Life Science

    Re–Vana Therapeutics Ltd

    Re–Vana Therapeutics is an ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of innovative long–acting biodegradable drug delivery platforms to treat chronic eye diseases.

    Read more
  • Life Science, Engineering

    Causeway Sensors Ltd

    Causeway Sensors are revolutionising the discovery and development of biotherapeutics using label–free plasmonic nanostructures

    Read more
  • Life Science

    Fusion Antibodies PLC

    Fusion Antibodies is dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry.

    Read more